Moderna CEO Says Its Coronavirus Vaccine Could Be Effective for Years

It's possible that two jabs of Moderna's (NASDAQ:MRNA) recently authorized coronavirus vaccine will be sufficient for long-term protection against the global health scourge. On Thursday, the company's CEO Stephane Bancel said at a healthcare industry event that this is a likely possibility, due to the durability of the antibodies the vaccine produces.